FDA clears Roche’s vitamin D laboratory test
26 July 2012 | By Roche
Fully automated assay for widely available platforms offers labs efficient solution to help assess patient vitamin D levels...
List view / Grid view
26 July 2012 | By Roche
Fully automated assay for widely available platforms offers labs efficient solution to help assess patient vitamin D levels...
23 July 2012 | By Roche
Almost four times as many patients achieve remission with RoActemra (tocilizumab) compared to Humira (adalimumab)...
19 July 2012 | By Roche
The system will be available in the United States in the second half of 2012...
27 June 2012 | By Roche
Roche site in Nutley (New Jersey, USA) to be closed – respective R&D activities to be consolidated in Switzerland and Germany...
22 June 2012 | By Roche
“We are pleased that Perjeta helped people with HER2-positive metastatic breast cancer..."
19 June 2012 | By Roche
Roche and Seaside Therapeutics have entered into a collaboration...
15 June 2012 | By Roche
Over 20,000 employees of Roche marked the International Day of the African Child...
11 June 2012 | By Roche
Roche announced that the U.S. FDA has approved PerjetaTM (pertuzumab)...
6 June 2012 | By Roche
Data announced from the ADACTA study...
16 May 2012 | By Roche
Phase III data on Avastin in advanced colorectal and ovarian cancers...
7 May 2012 | By Roche
Roche announced that following the results of the second interim analysis of the dalcetrapib dal-OUTCOMES Phase III trial...
3 May 2012 | By Roche
Roche announced that the SUMMACTA study met its primary endpoint...
18 April 2012 | By Roche
Roche released the following statement based on preliminary estimates...
6 April 2012 | By Roche
Roche released the following statement in response to a report issued by Institutional Shareholder Services...
30 March 2012 | By Roche
Roche have announced topline results of EMILIA...